在初级人类小岛细胞中多重复合的CRISPR基因编辑,使用Cas9核糖蛋白
Romina J Bevacqua1,2,3, Weichen Zhao1, Emilio Merheb2
1Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
bioRxiv : the preprint server for biology
|September 25, 2023
概括
人类小岛的CRISPR基因组编辑精确地准了调节性DNA. 这种方法揭示了与糖尿病风险和胰岛素分泌的遗传联系,进步了我们对β细胞功能的理解.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 了解人类小岛贝塔细胞的遗传调节对于了解糖尿病风险和功能至关重要.
- 初级人类小岛是研究β细胞生物学和疾病机制的重要模型.
结论:
- CRISPR/Cas9 RNP技术是研究人类小岛基因调节的强大工具.
- 这一策略有助于研究影响β细胞功能和糖尿病的遗传因素.
- 这些发现提升了我们在健康和疾病中在人类小岛细胞中阐明复杂的基因调节网络的能力.
相关概念视频
CRISPR/Cas9 Genome Editing
39
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
39
CRISPR
52.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.1K


